CARIBOU BIOSCIENCES, INC.

Insiders Caribou Biosciences, Inc.

Equities

CRBU

US1420381089

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-05 pm EDT			5-day change	1st Jan Change
2.12 ^USD	-2.08%		-26.39%	-63.00%

Jun. 04	US Equities Markets Close Mixed Monday as US Manufacturing Contracts	MT
Jun. 04	HC Wainwright Adjusts Price Target on Caribou Biosciences to $9 From $24, Maintains Buy Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Poseida Therapeutics Appoints Syed Rizvi as Chief Medical Officer	Mar. 25	MT
Caribou Biosciences, Inc. Appoints Tim Kelly as Chief Technology Officer	Jan. 07	CI
Syed Rizvi to Leave the Caribou Biosciences, Inc. as Chief Medical Officer, Effective from December 31, 2023	Dec. 12	CI
Caribou Biosciences, Inc. Appoints Sundar Jagannath to its Scientific Advisory Board	Nov. 06	CI
Caribou Biosciences, Inc. Appoints Reigin Zawadzki as Chief People Officer	23-09-27	CI
Caribou Biosciences Announces Appointment of Stephen J. Schuster, MD, to its Scientific Advisory Board	23-05-08	CI
Caribou Biosciences, Inc. Appoints Jason V. O'Byrne as Principal Accounting Officer	22-12-16	CI
Insider Sell: Caribou Biosciences	22-10-07	MT
Insider Sell: Caribou Biosciences	22-08-26	MT
Caribou Biosciences, Inc. Announces Board Changes	22-07-18	CI
Caribou Biosciences, Inc. Appoints David Johnson to its Board of Directors	22-05-11	CI
Caribou Biosciences, Inc. Appoints Syed Rizvi as Chief Medical Officer	22-01-18	CI
Caribou Biosciences, Inc. Announces Management Appointments	21-11-08	CI
Caribou Biosciences Appoints Ran Zheng to its Board of Directors	21-09-29	CI
Caribou Biosciences Appoints Nancy Whiting, Pharm.D., to its Board of Directors	21-08-25	CI
Caribou Biosciences, Inc. Announces Resignation of Jeffrey Long-McGie from the Company's Board of Directors	21-07-28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer